About Corestem
Corestem is a company based in Seongnam-si (South Korea) founded in 2003. Corestem operates in a competitive market with competitors including Blue Rock Therapeutics, CellCarta, Ascend, Impel Pharmaceuticals and Shanghai Cell Therapy Group, among others.
- Headquarter Seongnam-si, South Korea
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Corestem
Investors in Corestem
Corestem has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Korea-Seoul Life Science Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked |
Investor details for Corestem
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Corestem
Investment portfolio details for Corestem
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Corestem
Detailed financials for Corestem
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Corestem Comparisons
Peer comparison for Corestem
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Corestem
Corestem operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Blue Rock Therapeutics, CellCarta, Ascend, Impel Pharmaceuticals and Shanghai Cell Therapy Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Stem cell therapies are developed for cardiovascular and neurological diseases.
|
|
| Locked | Locked | Locked |
Histopathology and genomics services are offered by the CRO.
|
|
| Locked | Locked | Locked |
Online insurance payments and premium financing are enabled for businesses.
|
|
| Locked | Locked | Locked |
Transformative therapies are developed and commercialized through specialized services.
|
|
| Locked | Locked | Locked |
Research and development services for cell therapy are provided.
|
|
| Locked | Locked | Locked |
Online supplier and developer of RNA based products
|
Detailed competitors of Corestem
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Corestem
Complete news archive for Corestem
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Corestem
Corestem was founded in 2003 and raised its 1st funding round 9 years after it was founded.
Corestem is headquartered in Seongnam-si, South Korea. It is registered at Seongnam-si, Gyeonggi-do, South Korea.
Kyung Suk Kim is the current CEO of Corestem.
Corestem was founded in 2003 in Seongnam-si, South Korea, as a biotech firm. Stem cell-based therapies for incurable diseases are developed and produced by the company. Neuronata-R injection, an autologous bone marrow mesenchymal stem cell therapy, has been commercialized for Amyotrophic Lateral Sclerosis. Additional candidates, including CS20AT04 for Lupus and CS10BR05 for multiple system atrophy, are in the IND stage, while CS30MS02 for osteoarthritis remains in preclinical development.
Corestem's top competitors include Blue Rock Therapeutics, Ascend and CellCarta.
Corestem has 1 investor. Key investors include Korea-Seoul Life Science Fund.